TradingView
DEXWireNews
Apr 22, 2020 12:01 PM

Immunic Inc Rises on trial data  

NASDAQ:IMUX720
Immunic, Inc.NASDAQ

Description

⋅
shares are trading higher after the company reported its IMU-838 demonstrated preclinical activity against the coronavirus SARS-CoV-2 it is exploring plans for a Phase 2 clinical trial in coronavirus patients. Source seekignalpha
Trend AnalysisHarmonic PatternsChart Patterns
Comments
ProjectSyndicate
⋅
upvoted. great charts.
More